ENTIS members from the University of Oslo have developed a novel algorithm to more completely detect and date early pregnancy outcomes (i.e., miscarriages, elective terminations, […]
Welcome
ENTIS is a global collaborative network of Teratology Information Services. Member organisations consist of medical doctors, pharmacists, genetic counsellors and scientists all working together with the primary aim of preventing birth defects and developmental disorders which arise as a consequence of maternal or paternal perinatal exposures.
ENTIS member organisations work in three core areas:
ENTIS collaborates with researchers from a range of academic, industry and patient representative organisations. If you are interested in working with ENTIS or in joining our network, please contact us.
Alternatively, click here to learn more about ENTIS.
Latest Annual Conference News
Latest Teratology Studies
ENTIS and OTIS comment on the precautionary regulatory measures for paternal valproate use
ENTIS and OTIS have published an opinion article in Birth Defects Research which argues that the underlying scientific data do not convincingly substantiate the paternal […]
Suspected vertical transmission of Oropouche virus in pregnancy
The Pan American Health Organizartion (PAHO) has issued an epidemiological alert describing possible cases of vertical Oropouche virus transmission (from mother to fetus) in Brazil. […]
Data published from the COVACPREG French prospective cohort study of COVID-19 vaccination during pregnancy
A collaboration of researchers from two French University Hospitals, including one ENTIS member organisation, have published their CV-19 vaccine safety surveillance data. More information is […]
International collaborative study and systematic review of allopurinol safety in pregnancy
Data collected from Dutch and Danish clinical records has been used to investigate the safety of allopurinol use in pregnancy. The authors also conducted a […]
Manufacturer of golimumab publishes pregnancy safety data
Pregnancy safety data for golimumab have been published using global pharmacovigilance data collected by Janssen Pharmaceuticals. The authors of the publication concluded that rates of […]
No increased risk of major malformation following first trimester fluoroquinolone use
Researchers from the Pregnancy and Drug Information Center in Tokyo have published a comparative cohort study comparing fetal malformation outcomes between those exposed to (i) […]
Prenatal exposure to benzodiazepine and z-hypnotics and fifth-grade scholastic skills
A collaboration between researchers from the PharmacoEpidemiology and Drug Safety Research Group at the University of Oslo and the Department of Epidemiology at the University […]